Terumo Aortic Relay TEVAR

Introduction

Bolton Medical (Sunrise, Florida), now owned by Terumo (Tokyo, Japan), introduced the Relay thoracic endovascular aortic repair (TEVAR) endograft in 2005, with Phase II trials for approval in the United States beginning in 2007. In 2009, RelayPlus was introduced, which is now one of Bolton Medical’s main TEVAR endografts. While the endograft itself remained the same, the delivery system was updated. RelayPlus is the company’s only endograft approved for use in the United States by the Food and Drug Administration (FDA), receiving this approval on September 21, 2012.

Bolton Medical also manufactures RelayNBSPlus, an alternative to RelayPlus. Although the delivery system is the same, the RelayNBSPlus does not feature an uncovered fixation portion proximally. The company also offers customizable options for unique anatomy. As these two endografts lack FDA approval, this chapter will only focus on RelayPlus.